Good news.DM | 9 minutes ago Toronto, Ontario--(Newsfile Corp. - November 1, 2022) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the "Company" or "Datametrex'') is pleased to announce that further to the news release on October 25, 2022, Medi-Call Inc., ("Medi-Call"), the Company's wholly-owned telehealth company has received three (3) distribution agreements, signed October 28, 2022, with international student agencies following Medi-Call attending South Korea's International Education Fair last week to present its telehealth services to international students and agencies for studying in Canada. These new partnerships now connect Medi-Call with agencies that introduce services, such as healthcare to students who are planning their new journey into Canada. With an influx of new patients coming in from these agencies, Medi-Call's patient roster and telehealth subscribers are expected to grow significantly. Medi-Call is a growing telehealth platform designed to meet the current needs of Canadians and provide more affordable and accessible healthcare to those who need it. The latest Canadian healthcare data reports that 9.7 million Canadians are still having difficulty accessing healthcare, which includes 58% of those surveyed saying they have difficulty accessing specialist appointments, 54% saying they had difficulty accessing emergency care, 44% reporting difficulty accessing non-emergency treatment and 41% unable to access diagnostic tests. (Source: https://angusreid.org/canada-health-care-issues/) "With Medi-Call's team of highly skilled physicians and nurses, our telehealth services aim to fill the current void and help provide healthcare to those in need. Our affordable packages provide convenient and accessible healthcare at your fingertips. We are thrilled to now have partnerships that allow us to provide our telehealth services to international students. We are glad to see Medi-Call make progress and are expected to see more distribution agreements in the future," said Marshall Gunter, CEO of the Company